<DOC>
	<DOC>NCT01774500</DOC>
	<brief_summary>We study the hypothesis that combination of Proteine S100 beta and Copeptin within normal ranges can rule out seizure recurrences and severe outcome, and allow early discharge from the emergency department</brief_summary>
	<brief_title>Biomarkers In Seizure To Predict Recurrence and Severe Outcomes</brief_title>
	<detailed_description>Prospective study for a 12 month period in Paris (France) and London (UK). Inclusion criteria : - seizure within 24h of attendance to an Emergency department (ED) - or seizure in the ED Exclusion Criterie : - pregnancy - prisoneer Primary endpoint : - recurrence of seizure, hospitalisation more than 24 hours or death within seven days Secondary endpoint : - Hospital free days at day 7 and day 28 - Death, ICU admission, or neurosurgical intervention at day 7 and day 28 - Return visit to the ED or re admission at day 7 and day 28 data collection: - demographics - past medical history, medication - vital signs (Heart rate, temperature, Pulse oxymetry, blood pressure, GCS) on arrival - Pathology (White cell count, Sodium, Calcium, Glucose, lactate) - Protein S100B and Copeptin - Seizure characteristics (Witnessed, simple, partial, complex, provoked, acute symptomatic, idiopathic) - Discharge plan, outcomes Follow up at day 7 and day 28, hospital visit or phone call</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<criteria>Seizure within 24 hours of ED attendance Or Seizure in the ED Pregnancy Prisoner age &lt; 18 years old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>biomarkers</keyword>
	<keyword>Emergency Department</keyword>
	<keyword>Seizures</keyword>
	<keyword>epilepsy</keyword>
	<keyword>S100b</keyword>
	<keyword>copeptin</keyword>
</DOC>